PT Indofarma Tbk
PT Indofarma Tbk, a prominent player in Indonesia's pharmaceutical industry, is headquartered in Jakarta. Established in 1971, the company has evolved significantly, focusing on the production and distribution of a wide range of pharmaceutical products, including prescription medications, over-the-counter drugs, and herbal supplements. Indofarma is renowned for its commitment to quality and innovation, offering unique formulations that cater to diverse health needs. With a strong presence across various regions in Indonesia, the company has achieved notable milestones, including certifications that underscore its adherence to international standards. As a key contributor to the healthcare sector, PT Indofarma Tbk continues to strengthen its market position, driven by a dedication to improving public health and expanding access to essential medicines.
DitchCarbon Score
How does PT Indofarma Tbk's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PT Indofarma Tbk's score of 16 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
PT Indofarma Tbk's reported carbon emissions
PT Indofarma Tbk, headquartered in Indonesia, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing greenhouse gas emissions at this time. As a current subsidiary, PT Indofarma Tbk's climate initiatives and emissions data may be influenced by its corporate family relationships. However, no specific data or targets have been cascaded from a parent organisation or related entities. The absence of emissions data and reduction initiatives highlights a potential area for improvement in the company's environmental strategy. In the broader context of the pharmaceutical industry, companies are increasingly expected to adopt robust climate commitments and transparent reporting practices. PT Indofarma Tbk may benefit from aligning with industry standards and setting measurable targets to enhance its sustainability profile.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
PT Indofarma Tbk is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
